IPCA LABORATORIES
Back to Balance Sheet
|
IPCA LABORATORIES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹239 Cr | ₹119 Cr | ₹93 Cr | ₹70 Cr | ₹56 Cr |
What is the latest Contingent Liabilities ratio of IPCA LABORATORIES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹239 Cr |
| Mar2024 | ₹119 Cr |
| Mar2023 | ₹93 Cr |
| Mar2022 | ₹70 Cr |
| Mar2021 | ₹56 Cr |
How is Contingent Liabilities of IPCA LABORATORIES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹239 Cr | 100.76 | |
| Mar2024 | ₹119 Cr | 27.48 | |
| Mar2023 | ₹93 Cr | 34.12 | |
| Mar2022 | ₹70 Cr | 24.95 | |
| Mar2021 | ₹56 Cr | - | |
Compare Contingent Liabilities of peers of IPCA LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| IPCA LABORATORIES | ₹37,869.8 Cr | 4.1% | 0.3% | 5.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,062.0 Cr | 0.4% | 2.6% | NA | Stock Analytics | |
| DIVIS LABORATORIES | ₹164,192.0 Cr | -4.5% | 0.7% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,129.0 Cr | 5% | 4.1% | 37.2% | Stock Analytics | |
| CIPLA | ₹108,513.0 Cr | -0.5% | -3.4% | -6.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,250.0 Cr | 1.2% | 10.2% | 4.8% | Stock Analytics | |
IPCA LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| IPCA LABORATORIES | 4.1% |
0.3% |
5.7% |
| SENSEX | -1% |
-0.1% |
7.9% |
You may also like the below Video Courses